Daniel Lochner

Inga fler pågående positioner

Förmögenhet: 2 M $ per 2026-05-31

44 år

81 relationer

Health Technology

Consumer Services

Commercial Services

Profil

Daniel Lochner is currently Chief Financial Officer at Tectonic Therapeutic, Inc. and Chief Financial Officer at Tectonic Operating Co., Inc., both starting in 2024.
Former positions include Chief Financial Officer at AVROBIO, Inc. in 2024, Chief Financial & Business Officer-Eye Care at Viatris, Inc. from 2023 to 2024, Chief Financial & Business Officer at Oyster Point Pharma, Inc. from 2022 to 2023, and Portfolio Manager at Goldman Sachs Asset Management LP from 2005 to 2019.
Education includes an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Richmond.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
0,31 %	2026-06-11	58 544 ( 0,31 % )	2 M $	2026-05-31

Aktiva positioner av Daniel Lochner

Företag	Position	Start
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies	Finansdirektör/CFO	2024-06-01

Alla aktiva positioner av Daniel Lochner

Tidigare kända positioner av Daniel Lochner

Företag	Position	Slut
VIATRIS INC.	Företagsledare/Principal	2024-04-01
OYSR POIN	Finansdirektör/CFO	2023-01-01
Goldman Sachs Asset Management LP Goldman Sachs Asset Management LP Investment ManagersFinance GSMALP offers a wide array of investment strategies that span asset classes, industries, and geographies. The firm's products and services across a full range of asset classes including fixed income, money markets, public and private equity, commodities, hedge funds, and real estate. Clients access these solutions through GSAM's proprietary strategies, strategic partnerships, and open architecture programs.	Portföljförvaltare-Aktier	2019-07-01
TECTONIC THERAPEUTIC, INC.	Finansdirektör/CFO	-

Se detaljerna i Daniel Lochners erfarenhet

Daniel Lochners utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Daniel Lochners erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	7
Goldman Sachs Asset Management LP Goldman Sachs Asset Management LP Investment ManagersFinance GSMALP offers a wide array of investment strategies that span asset classes, industries, and geographies. The firm's products and services across a full range of asset classes including fixed income, money markets, public and private equity, commodities, hedge funds, and real estate. Clients access these solutions through GSAM's proprietary strategies, strategic partnerships, and open architecture programs.	Finance
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Richmond University of Richmond Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AVROBIO, Inc. AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose	Health Technology
Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases	Commercial Services
Viatris, Inc. Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products	Health Technology
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies	Commercial Services